Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. We provide innovative products and services in more than 50 countries around the world. With more than 100 years of scientific expertise, our company draws upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
Disclaimer This website contains information on LIXIANA (edoxaban), which is based on the Summary of Product Characteristics (SPC) as approved by the European Commission. It is intended to provide information to a UK healthcare professional audience.
Date of preparation: October 2018 EDX/18/0196(1)
Daiichi Sankyo UK Limited
Chiltern Place, 1 Chalfont Park, Chalfont St Peter, Gerrards Cross SL9 0GA